iifl-logo

Goldline Pharmaceutical Ltd Company Summary

Add as a Preferred Source on Google
48.44
(4.98%)
May 29, 2026|05:30:00 AM

Goldline Pharmaceutical Ltd Summary

Goldline Pharmaceutical Limited was originally incorporated on August 2, 2004, as a private limited Company in the name of Goldline Pharmaceutical Private Limited with the Registrar of Companies, Mumbai. Subsequently, Company was converted into a public limited Company and the name of Company was changed to Goldline Pharmaceutical Limited w.e.f. September 23, 2013.

Company is engaged in the business of marketing pharmaceutical products under the Goldline brand. Their products are divided into five categories: Goldline Pharma, Goldline Cardinal, Goldline Aayushman, Goldline InLife, and Goldline Valiente. The pharmaceutical products marketed under the Goldline brand are not manufactured by Company.

Instead, they enter into contractual arrangements with third-party manufacturers, who produce the products based on market research, demand analysis, and specifications. Presently, Company maintain contractual arrangements with 15 manufacturers and 7 distributors, ensuring a stable supply chain and consistent market presence.Company extend comprehensive material supply and procurement support to hospitals and healthcare partners. Through the promoter group entities as Numerius Healthcare Pvt Ltd & Activista Healthcare Pvt Ltd, Company manage trading and supply chain operations, thereby ensuring reliable procurement, seamless distribution, and logistical efficiency.Company is planning the Initial Public Offer of 30,00,000 Equity Shares having the face value of Rs 10 each through Fresh Issue.
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.